New Results
Tumor subclonal progression model for cancer hallmark acquisition
View ORCID ProfileYusuke Matsui, Satoru Miyano, Teppei Shimamura
doi: https://doi.org/10.1101/149252
Yusuke Matsui
1 Nagoya University Graduate School of Medicine, Division of Systems Biology, 65 Tsurumai-cho Showa-ku, Nagoya, 466-8550, Japan,
Satoru Miyano
2 Institute of Medical Science, The University of Tokyo, Laboratory of DNA Information Analysis, Human Genome Center, 4-6-1 Shirokanedai, Minatoku, Tokyo 108-8639, Japan
Teppei Shimamura
1 Nagoya University Graduate School of Medicine, Division of Systems Biology, 65 Tsurumai-cho Showa-ku, Nagoya, 466-8550, Japan,

Article usage
Posted June 12, 2017.
Tumor subclonal progression model for cancer hallmark acquisition
Yusuke Matsui, Satoru Miyano, Teppei Shimamura
bioRxiv 149252; doi: https://doi.org/10.1101/149252
Subject Area
Subject Areas
- Biochemistry (8773)
- Bioengineering (6487)
- Bioinformatics (23356)
- Biophysics (11758)
- Cancer Biology (9155)
- Cell Biology (13257)
- Clinical Trials (138)
- Developmental Biology (7418)
- Ecology (11376)
- Epidemiology (2066)
- Evolutionary Biology (15095)
- Genetics (10404)
- Genomics (14014)
- Immunology (9126)
- Microbiology (22071)
- Molecular Biology (8783)
- Neuroscience (47397)
- Paleontology (350)
- Pathology (1421)
- Pharmacology and Toxicology (2482)
- Physiology (3705)
- Plant Biology (8055)
- Synthetic Biology (2211)
- Systems Biology (6017)
- Zoology (1250)